Transformative Therapies for Autoimmune Diseases
  • LinkedIn
  • Twitter
  • Svenska
  • About
    • About Cyxone
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Therapy Areas
    • Autoimmune and Autoinflammatory Diseases
    • Rheumatoid Arthritis
    • Multiple Sclerosis
  • Pipeline
    • Our Projects
    • Rabeximod
    • T20K
    • Intellectual Property
  • Investors
    • Investor Relations
    • Share information
    • Owners
    • Financial Reports
    • Financial Calendar
    • Share issues
    • Analysts
    • Corporate governance
    • General Meetings
  • News
    • News
    • Press Releases
    • Cyxone in media
    • Company Presentations
    • Events

Cyxone in media Latest News

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

Apr 4, 2016

http://www.pnas.org/content/early/2016/03/22/1519960113.full.pdf

http://tvthek.orf.at/program/ZIB-1/1203/ZIB-1/12317916/Hoffnung-fuer-Multiple-Sklerose-Patienten/12318077

Address

Cyxone AB
Hyllie Boulevard 34
215 32 Malmö
Sweden

Contact

Phone: +46 707 81 88 08
E-Mail: info@cyxone.com

GDPR Policy

Social media

LinkedIn

Copyright © 2020 Cyxone AB. All Rights Reserved. Design by Clavis Communications.
We only use cookies that are necessary for the function of the website. No cookies are used for analysis or marketing purpose.
Accept
Manage consent

Cookies

Vi placerar inga analys- eller marknadsföringscookies utan enbart cookies som är nödvändiga för hemsidans funktion.
SAVE & ACCEPT